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  Chinese Hamster Ovary (CHO) cells are the preferred hosts for the production of 
therapeutic glycoproteins. However, there is a need for improvement of the bioprocesses towards 
increased cell growth and higher productivities without compromising the product quality. Efforts 
to obtain tailor-made products with the desired properties that meet the requirements of 
regulatory authorities are continuously being made. Of equal relevance is to develop methods to 
engineer cell lines with improved by-product metabolism. 
  CHO cells are not efficient at converting substrate into product or biomass. At the 
moment, up to 50% of the carbon fed to the cells is wasted in toxic non-productive by-products, 
like lactate and ammonium that accumulate throughout the culture time in mammalian cells, that 
reduce the potential cell growth rate and protein productivity.  
As genome sequences of CHO cell lines and draft genome of Cricetulus griseus (Chinese Hamster), 
alongside genome editing tools like CRISPR/Cas9 are recently available, an “omics” approach for 
studying the CHO metabolism is now possible. This allows for reengineering cell lines towards a 
more efficient metabolism and higher cell densities. 
  The methodology includes reviewing the literature in search of potential targets 
affecting cell growth and productivity, using CRISPR/Cas9 for genome engineering to knock-out 
and/or knock-in target genes in order to produce cell lines with improved phenotypes. In addition, 
for assessment of the genome engineering, DNA-seq, RNA-seq and proteomics are also used. 
Moreover, the phenotypes of the different clones are characterized in batch and bioreactor 
cultivations. 
  The effects of genome engineering of candidate genes are being assessed alongside data 
on specific rates for uptake and formation of nutrients, metabolites and by-products. Based on 
these, enhanced CHO cell lines potentially producing reduced amounts of by-products will 
confirm the success of the cell line engineering strategy. 
 
 
 
 
  
